8-K
filed July 3, 2023, 7:59 PM ET
ticker CLB
CIK 0001958086
other
confidence high
sentiment neutral
materiality 0.15
Core Labs shareholders elect directors, approve KPMG, say-on-pay, director plan
Core Laboratories Inc. /DE/
- Harvey Klingensmith and Curtis Anastasio elected as Class I directors with 33.6M and 37.3M votes for, respectively.
- Ratification of KPMG as auditor approved: 40.5M for, 62.5K abstain.
- Advisory vote on executive compensation approved: 36.2M for, 1.3M against.
- Shareholders selected 1-year frequency for say-on-pay votes (35.9M votes for 1 year).
- Director Plan amendment extending term to 2033 approved: 36.3M for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Core Laboratories Inc. /DE/ shareholders approved Election of Class I Directors at the 2023-06-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 1 – Election of Class I Directors : The election of each Class I director was approved as follows: Nominee For Withheld Broker Non-Votes Harvey Klingensmith 33,648,480 4,593,058 3,280,551 Curtis Anastasio 37,297,840 943,698 3,280,551
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Core Laboratories Inc. /DE/ shareholders approved Advisory vote on frequency of shareholder votes on executive compensation at the 2023-06-28 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 3b – Approving the Frequency of Compensation of the Company’s Executive Officers : The selection of the frequency of shareholder votes on the compensation of the Company’s named executive officers was determined as follows: 1 Year 2 Years 3 Years Abstentions Broker Non-Votes 35,944,561 10,314 2,247,398 39,265 3,280,551
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Core Laboratories Inc. /DE/ shareholders approved Advisory vote to approve compensation of executive officers at the 2023-06-28 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 3a – Approving the Compensation of the Company’s Executive Officers : The compensation of the Company’s named executive officers was approved, on an advisory basis, as follows: For Against Abstentions Broker Non-Votes 36,172,862 1,265,529 803,147 3,280,551
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Core Laboratories Inc. /DE/ shareholders approved Amendment and restatement of 2014 Non-Employee Director Stock Incentive Plan to extend term through June 28, 2033 at the 2023-06-28 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 4 – Approve Extension of the Director Plan : The amendment and restatement of the Director Plan, the principal purpose of which is to extend the term of the Director Plan through June 28, 2033 was approved as follows: For Against Abstentions Broker Non-Votes 36,300,313 1,801,924 139,301 3,280,551
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Core Laboratories Inc. /DE/ shareholders approved Ratification of appointment of KPMG LLP as independent registered public accountants at the 2023-06-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 2 – Appointment of KPMG as Independent Registered Public Accountant: The ratification of the appointment of KPMG as the independent registered public accountant for the fiscal year ending December 31, 2023 was approved as follows: For Against Abstentions Broker Non-Votes 40,549,322 910,252 62,515 —
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.